These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 28580582)

  • 1. Modulating inflammation and neuroprotection in multiple sclerosis.
    Yong H; Chartier G; Quandt J
    J Neurosci Res; 2018 Jun; 96(6):927-950. PubMed ID: 28580582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotherapies in multiple sclerosis: a step toward remyelination and neuroprotection?
    Dubessy AL; Zujovic V; Papeix C; Stankoff B
    Rev Neurol (Paris); 2014 Dec; 170(12):770-8. PubMed ID: 25459127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preactive multiple sclerosis lesions offer novel clues for neuroprotective therapeutic strategies.
    van Noort JM; van den Elsen PJ; van Horssen J; Geurts JJ; van der Valk P; Amor S
    CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):68-81. PubMed ID: 21143143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection in multiple sclerosis: a therapeutic approach.
    Maghzi AH; Minagar A; Waubant E
    CNS Drugs; 2013 Oct; 27(10):799-815. PubMed ID: 23955320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulating processes within the central nervous system is central to therapeutic control of multiple sclerosis.
    Ziemssen T
    J Neurol; 2005 Nov; 252 Suppl 5():v38-45. PubMed ID: 16254701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and pathological topics of multiple sclerosis].
    Lassmann H
    Rinsho Shinkeigaku; 2009 Nov; 49(11):715-8. PubMed ID: 20030193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulation neuroprotection and remyelination - the fundamental therapeutic effects of glatiramer acetate: a critical review.
    Aharoni R
    J Autoimmun; 2014 Nov; 54():81-92. PubMed ID: 24934599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis.
    Xiao J; Yang R; Biswas S; Zhu Y; Qin X; Zhang M; Zhai L; Luo Y; He X; Mao C; Deng W
    Mol Neurobiol; 2018 Apr; 55(4):3152-3171. PubMed ID: 28466274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decade.
    Van der Walt A; Butzkueven H; Kolbe S; Marriott M; Alexandrou E; Gresle M; Egan G; Kilpatrick T
    Pharmacol Ther; 2010 Apr; 126(1):82-93. PubMed ID: 20122960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axonal loss in multiple sclerosis: causes and mechanisms.
    Criste G; Trapp B; Dutta R
    Handb Clin Neurol; 2014; 122():101-13. PubMed ID: 24507515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotection and repair in multiple sclerosis.
    Franklin RJ; ffrench-Constant C; Edgar JM; Smith KJ
    Nat Rev Neurol; 2012 Nov; 8(11):624-34. PubMed ID: 23026979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
    Olsen JA; Akirav EM
    J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prospect of stem cells as multi-faceted purveyors of immune modulation, repair and regeneration in multiple sclerosis.
    Payne N; Siatskas C; Barnard A; Bernard CC
    Curr Stem Cell Res Ther; 2011 Mar; 6(1):50-62. PubMed ID: 20955155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuroprotection in the treatment of multiple sclerosis].
    Zipp F; Gold R
    Nervenarzt; 2011 Aug; 82(8):973-7. PubMed ID: 21761185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis: an immune or neurodegenerative disorder?
    Trapp BD; Nave KA
    Annu Rev Neurosci; 2008; 31():247-69. PubMed ID: 18558855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifaceted involvement of microglia in gray matter pathology in multiple sclerosis.
    Tsouki F; Williams A
    Stem Cells; 2021 Aug; 39(8):993-1007. PubMed ID: 33754376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lesion Expansion in Experimental Demyelination Animal Models and Multiple Sclerosis Lesions.
    Große-Veldmann R; Becker B; Amor S; van der Valk P; Beyer C; Kipp M
    Mol Neurobiol; 2016 Sep; 53(7):4905-17. PubMed ID: 26363796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remyelinating strategies in multiple sclerosis.
    Luessi F; Kuhlmann T; Zipp F
    Expert Rev Neurother; 2014 Nov; 14(11):1315-34. PubMed ID: 25331418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linkage between immunomodulation, neuroprotection and neurogenesis.
    Aharoni R; Arnon R
    Drug News Perspect; 2009; 22(6):301-12. PubMed ID: 19771319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.